Abdominal and Metoprolol


Abdominal Symptoms and Causes

Your abdomen extends from below your chest to your groin. Some people call it the stomach, but your abdomen contains many other important organs. Pain in the abdomen can come from any one of them. The pain may start somewhere else, such as your chest. Severe pain doesn't always mean a serious problem. Nor does mild pain mean a problem is not serious.

Call your health care provider if mild pain lasts a week or more or if you have pain with other symptoms. Get medical help immediately if

  • You have Abdominal pain that is sudden and sharp
  • You also have pain in your chest, neck or shoulder
  • You're vomiting blood or have blood in your stool
  • Your abdomen is stiff, hard and tender to touch
  • You can't move your bowels, especially if you're also vomiting

Check out the latest treatments for abdominal

abdominal treatment research studies

Metoprolol clinical trials, surveys and public health registries

Find Drug Side Effect reports

Metoprolol Side Effects

Bradycardia (410)
Dizziness (389)
Hypotension (291)
Blood Pressure Increased (282)
Dyspnoea (271)
Fatigue (258)
Completed Suicide (244)
Syncope (220)
Nausea (195)
Headache (188)
Chest Pain (166)
Palpitations (160)
Asthenia (152)
Diarrhoea (151)
Atrial Fibrillation (147)
Hypertension (145)
Pain (140)
Heart Rate Increased (131)
Anxiety (131)
Myocardial Infarction (129)
Fall (115)
Pain In Extremity (111)
Malaise (110)
Toxicity To Various Agents (104)
Oedema Peripheral (102)
Pruritus (101)
Product Substitution Issue (101)
Product Quality Issue (99)
Heart Rate Decreased (96)
Insomnia (96)
Cerebrovascular Accident (96)
Cardiac Arrest (89)
Rash (89)
Vomiting (87)
Feeling Abnormal (86)
Renal Failure (83)
Renal Failure Acute (83)
Depression (83)
Confusional State (78)
Blood Pressure Decreased (77)
Arthralgia (76)
Death (73)
Chest Discomfort (73)
Tachycardia (71)
Loss Of Consciousness (69)
Somnolence (69)
Hyperhidrosis (65)
Cardiogenic Shock (63)
Condition Aggravated (63)
Weight Decreased (62)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

When I eat or drink this burning feeling in my chest going up like I am about vomiting.what is happening? And something I and chest pain too! And I am 14 and a girl

<strong>I was put on Metoprolol ER 2 years ago after having cancer. I was </strong><span style='text-decoration: underline;'>tired all day could not sleep at night, had anxiety attacks, co

I have been taking Toprol XL 100 for 7 yrs with no issues or changes in my EKGs. I was switched to the Generic Metoprolol 50mg twice a day 3 months ago. I started experiencing PVCs and stomach trouble. Went to the ER twice becaus

i've been on the generic metoprolol for 3 days. dr. started me on 25mg 2x per day and i've been experiencing shortness of breath, chest discomfort and dizziness. i cut the dosage down to 6.5mg per day and feel a little better (palpations&

<strong>Tired all the time. Sleep poorly. Dry hacking cough and I am cold all the time. I can't seem to keep warm. I doubleup on my clothing and socks.</strong> <strong>Honestly, I have never

A 40-year-old manager, at a prominent legal firm in L.A., experiences abdominal pain post lunch. He goes to the restroom a couple of times, but continues to experience pain and cramps. He eventually decides to get himself examined. While questioning

Can i take Acetaminophen W/Codeine #3 with Metoprolol er succinate 25 mg ?

Dehydration causes uterine contractions which causes cramping. you should drink more water!

Does anyone have a nagging cough while taking metaprolol?

Does it hurt in your legs real bad, you can't sleep and your chest hurts? See your Doctor.

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

I took one Aleve at 3:30 PM and by 6:30 PM I had extreme abdominal pain lasting several hours and now the next day I still am uncomfortable. I will never take Aleve again!!


<b>After taking this drug I suffered abdominal pain with diarrhea after eating even small amounts, pain developed with the urge to get to a toilet at once. I had a full blood and liver test and a stool test and all was normal.&nbs

<b>Describe Your Ezetrol Experience Here:</b>Sleeplessness severe pain in muscles and joints nausea and abdominal pain headaches and pain behind eyes chronic fatigue and flat mood

More common<span style='padding-top: 5px; padding-right: 0px; padding-bottom: 5px; padding-left: 30px; color: #444444; display: block;'>- Abdominal pain<span style='padding-top: 5px; padding-right: 0px; padd

25 YR OLD TRAPSPATIENT w/abdominal pain x 10 days. Stopped taking 100mg dail Kineret 3 days ago, now w/fever 100/102. Went to ER 5 days ago, w/no sign of inflammation in labs. Still have severe abdominal pain.&nbsp

Bad taste in my mouth, very bloated and abdominal pain and reflux

25 three boys. I have loved it. Only problem is occasional abdominal pains. Tonight after intercourse i started spotting and i am concerned as i have had this devise for several months and have never experienced this. I found out later that many wome

32 days on ezertrol 10mg and have severe abdominal cramping and look 6months pregnant, don't know where to go from here, back to the Doctor!!!

Abdominal Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Intra-Abdominal Pressure Monitoring in Patients With Open Abdomen Undergoing Early Closure
Condition: Open Wound of Other and Unspecified Parts of Abdomen
Intervention: Device: AbViser Abdominal compartment pressure measuring device
Outcome Measures: Intra-Abdominal pressure (IAP) Measurements;   Length of time in critical care unit
2 Recruiting Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children
Conditions: Abdominal Pain;   Constipation - Functional
Interventions: Dietary Supplement: Administration of L.reuteri in children with Abdominal pain;   Dietary Supplement: Administration of placebo in children with Abdominal pain;   Dietary Supplement: Administration of L.reuteri in children with constipation;   Dietary Supplement: Administration of placebo in children with constipation
Outcome Measures: Intensity of Abdominal pain;   Severity of chronic constipation;   Intensity of Abdominal pain after treatment;   Severity of chronic constipation after treatment
3 Unknown  Laparotomy Versus Percutaneous Puncture in Patients With Abdominal Compartment Syndrome During Acute Pancreatitis
Conditions: Mortality;   Acute Pancreatitis
Interventions: Procedure: Decompressive laparotomy with temporary Abdominal closure;   Procedure: Percutaneous puncture with placement of Abdominal catheter
Outcome Measures: Mortality rate during the hospital stay for patients with Abdominal compartment syndrome during acute pancreatitis.;   duration time of organ failure;   development of a new organ failure;   number of infectious complications,;   needs for necrosectomy,;   intensive care stay;   total hospital stay
4 Recruiting Screening for Abdominal Aortic Aneurysm and Abdominal Aortic Atherosclerosis by Hand-Held Ultrasonography
Conditions: Hypertension;   Abdominal Aortic Aneurysm;   Atheromatosis
Intervention: Device: Ultrasound (Trademark:VScan; Manufacturer:General Electrics)
Outcome Measures: Number of patients with Abdominal aortic aneurysm detected by a Hand-held ultrasound in Primary Care.;   Number of patients with Abdominal aortic atheromatosis detected by Hand-held ultrasound in Primary Care
5 Recruiting Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP
Condition: Pancreatitis
Interventions: Other: Early stage Abdominal drainage;   Other: Late stage Abdominal drainage
Outcome Measures: Rates of ACS in 28 days since outbreaks;   Rates of surgical interfere, MODS or death in 6 months since outbreaks
6 Recruiting Reinforcement of the Abdominal Wall After Breast Reconstruction With the Pedicled TRAM-flap
Condition: Abdominal Donor-site
Interventions: Device: Biological mesh;   Device: Synthetic mesh
Outcome Measures: Abdominal wall function change;   Abdominal donor site morbidity;   Aesthetics at the Abdominal wall;   Costs;   Postoperative complications
7 Recruiting Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity
Condition: Obesity, Abdominal
Interventions: Other: Urine sample;   Other: Blood sample;   Other: Assessment of sleep apnea syndrome;   Other: Electrocardiogram;   Other: Glucose tolerance test;   Other: Echocardiography;   Other: cardiac and Abdominal magnetic resonance imaging;   Other: Ambulatory blood pressure monitoring;   Other: Echotracking;   Other: Pulse wave velocity;   Other: Composition of body mass by Dual x-ray absorptiometry
Outcome Measures: cardiac extracellular matrix remodelling;   Cardiac and arterial phenotype
8 Not yet recruiting Limited Abdominal CT in ED Patients With Abdominal Pain
Condition: Abdominal Pain
Intervention: Other: non interventional study
Outcome Measures: Diagnosis, treatment and disposition;   radiation reduction
9 Recruiting The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery
Conditions: Aortic Aneurysm, Abdominal;   Arterial Occlusive Diseases
Intervention: Procedure: Abdominal aortic surgery
Outcome Measures: cardiovascular morbidity and mortality;   all cause mortality
10 Recruiting Sepsis and Abdominal Drainage
Conditions: Abdominal Compartment Syndrome;   Intra-Abdominal Hypertension
Interventions: Device: KCI AbThera;   Device: "Stampede" VAC
Outcome Measures: Systemic inflammatory marker levels and peritoneal fluid inflammatory marker levels;   Physiological Outcomes;   Global Outcomes
11 Recruiting HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm
Conditions: Infrarenal Abdominal Aortic Aneurysms;   Aortoiliac Aneurysms
Intervention: Device: Horizon™ Abdominal Aortic Aneurysm Stent Graft System
Outcome Measures: Safety endpoint: Major adverse events;   Performance endpoint;   MAEs;   Mortality;   secondary performance endpoint
12 Not yet recruiting The Effect of Postoperative Abdominal Binder to Improve Outcomes After Incisional Hernia Repair
Condition: Incisional Hernia
Intervention: Device: Abdominal binder
Outcome Measures: seroma formation;   postoperative pain
13 Unknown  Treatment Duration for Abdominal Tuberculosis
Condition: Treatment Duration for Abdominal Tuberculosis
Interventions: Drug: RNTCP Category I treatment for 6 months;   Drug: RNTCP Category I treatment for 9months
Outcome Measures: Response to treatment (after 6 months and nine months of RNTCP Category I treatment);   Recurrence of symptoms of Abdominal tuberculosis (intestinal and peritoneal) after 1 year of follow up in those who receive 6 months or 9 months of Cat I treatment
14 Unknown  The Influence of Furosemide on Fluid Balance and Intra-Abdominal Pressure in Critically Ill Patients
Condition: Intra-Abdominal Hypertension
Intervention: Drug: furosemide
Outcome Measures: intra-Abdominal pressure;   serum creatinine;   need for renal replacement therapy;   ICU mortality;   acid-base status;   hospital and 28d mortality;   duration of mechanical ventilation;   ICU length of stay;   vasopressor dose;   fluid balance;   SOFA score
15 Unknown  Assessment of Peritoneal Immune Response in Patients With Severe Intra-Abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)
Condition: Abdominal Sepsis
Outcome Measures: Measure peritoneal immune response to intra-Abdominal sepsis;   General characteristics
16 Recruiting Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments
Conditions: Wound Healing Disorder;   Impaired Wound Healing;   Abdominal Wound Healing Disorder;   Abdominal Wound Healing Impairment;   Acute Postsurgical Subcutaneous Wound
Interventions: Device: Vacuum Assisted Closure®;   Other: Standard conventional wound therapy
Outcome Measures: Time to complete wound closure;   Incidence of confirmed and verified wound closure;   Recurrence;   Wound size over time;   Serious Adverse Events (SAE);   Adverse Events;   Mortality;   Quality of Life (QoL);   Pain;   Patient Satisfaction;   Direct resource use;   Indirect resource use
17 Recruiting Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac
Condition: Abdominal Aortic Aneurysm
Intervention: Procedure: EVAR without coils embolization/ Coils embolization during EVAR
Outcome Measures: Evaluation at one month the presence or absence of endoleak type II in all patients for each group by Computer Tomography and Doppler.;   • Evaluation at 6, 12 and 24 months by CT and doppler: -The rate of type II endoleak;   • Mortality and morbidity .;   • Number of additional procedures -endovascular -surgical;   • Complications of endovascular procedures away from the EVAR -Thrombosis of leg -Limb occlusion -Evolution of the aneurysmal neck;   • Monitoring of renal function (creatinine clearance).;   • Evaluation at 6, 12 and 24 months by CT and doppler: -Measurement of the maximum transverse aneurysm diameter;   • Evaluation at 6, 12 and 24 months by CT and doppler: -volumetric measurement of the sac aneurysmal
18 Recruiting Breast and Abdominal Related Morbidity of DIEP and SIEA Flaps
Conditions: DIEP Flap Breast Reconstruction;   SIEA Flap Breast Reconstruction
Interventions: Procedure: DIEP flap breast reconstruction;   Procedure: SIEA flap breast reconstruction
Outcome Measures: Change in objective isokinetic Abdominal strength;   Breast-Q questionnaire;   Fat Necrosis;   Seroma Rate and Drainage Volumes;   Flap Loss;   Abdominal Wound Breakdown;   Intra-Operative Outcomes:;   Clinical Abdominal Examination
19 Recruiting Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)
Conditions: Parkinson's Disease;   Neurogenic Orthostatic Hypotension in Parkinson's Disease
Interventions: Device: Elastic Abdominal binder;   Device: Placebo binder
Outcome Measures: Effect of an elastic Abdominal binder versus a placebo binder on mean blood pressure (mmHg) after 3 minutes of orthostatic challenge (on passive tilting) with respect to baseline in Parkinson's disease patients with neurogenic orthostatic hypotension;   Effect of an elastic Abdominal binder versus a placebo binder on systolic blood pressure (mmHg) after 3 minutes of orthostatic challenge with respect to baseline in Parkinson's disease patients with neurogenic orthostatic hypotension;   Effect of an elastic Abdominal binder versus a placebo binder on diastolic blood pressure (mmHg) after 3 minutes of orthostatic challenge with respect to baseline in Parkinson's disease patients with neurogenic orthostatic hypotension;   Effect of an elastic Abdominal binder with respect to a placebo binder on orthostatic symptoms after 3 minutes of orthostatic challenge in Parkinson's disease patients suffering from neurogenic orthostatic hypotension;   Effect of an elastic Abdominal binder with respect to a placebo binder on mean supine blood pressure (mmHg) in Parkinson's disease patients suffering from neurogenic orthostatic hypotension;   Effects of an Abdominal binder on orthostatic symptoms in daily living during 4-weeks open label trial;   Effect of an elastic Abdominal binder versus a placebo binder on mean blood pressure (mmHg) after 3 minutes of orthostatic challenge (on active standing) with respect to baseline in Parkinson's disease patients with neurogenic orthostatic hypotension
20 Recruiting The Use of Abdominal Binders in Patients Undergoing Cesarean Sections
Condition: Cesarean Section Post Operative Management
Intervention: Device: Abdominal Binder
Outcome Measures: Pain measurement;   Patient Distress score;   hemoglobin and hematocrit;   Pain medication usage